Navigation Links
MUHC investigators search for the root of sexual pain in women

A multidisciplinary team consisting of researchers from McGill/MUHC and the CHUM have been awarded a grant of nearly $700,000 by the Canadian Institutes of Health Research (CIHR) to continue their groundbreaking research on pain suffered by some women during sexual intercourse. The new funding will allow the team, consisting of psychologists, gynecologists, physical therapists and statistician/epidemiologists, to root-out the cause of a condition experienced recurrently by at least 15% of Canadian women.

The research team will focus specifically on two main areas of study: dyspareunia (pain during sexual intercourse) and vaginismus (vaginal spasm preventing intercourse). These conditions, which were previously considered sexual dysfunctions, are now increasingly understood as pain disorders as a result of previous research by this team. "Approaching this problem in the context of pain is a more accurate and positive step," says the study's lead researcher Dr. Irv Binik, Director of the Sex and Couple Therapy Service at the MUHC and Professor of Psychology at McGill University. "It opens the door to new therapeutic possibilities including cognitive-behavioral pain management, physical therapy, surgery and alternate pain medication, which will hopefully result in fewer women suffering in silence."

The new CIHR grant will allow the team to initiate research with groups of women that suffer from genital pain associated with menopause--one of the most common forms of dyspareunia. The research concerning vaginismus will focus on the role of fear in sexual intercourse--the major roadblock to therapeutic efforts. "Women suffering from vaginismus seem to avoid and fear vaginal penetration more than women suffering from other genital pain disorders," noted Dr. Binik. "A better understanding of the specific features of both vaginismus and dyspareunia will undoubtedly lead to more appropriate and effective treatments."

Patients who wish to be involved in this study, or wish to learn more about sexual pain in women should contact:


'"/>

Source:McGill University


Related biology news :

1. Gladstone investigators discover how resting T cells avoid HIV infection
2. Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G
3. Researchers discover way to make cells in the eye sensitive to light
4. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
5. Columbia research lifts major hurdle to gene therapy for cancer
6. Researchers find how protein allows insects to detect and respond to pheromones
7. Researchers Uncover Key Step In Manufacture of Memory Protein
8. Research advances quest for HIV-1 vaccine
9. Research on Worms Yields Clues on Aging
10. U of M researcher examines newly emerging deadly disease
11. NYU researchers simulate molecular biological clock
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology: